Development of PARP inhibitor combinations for castration resistant prostate cancer unselected for homologous recombination repair mutations.

Saved in:
Bibliographic Details
Title: Development of PARP inhibitor combinations for castration resistant prostate cancer unselected for homologous recombination repair mutations.
Authors: McFarland TR; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah Salt Lake, UT, USA., Kessel A; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah Salt Lake, UT, USA., Swami U; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah Salt Lake, UT, USA., Agarwal N; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah Salt Lake, UT, USA.
Source: American journal of translational research [Am J Transl Res] 2021 Jul 15; Vol. 13 (7), pp. 7427-7439. Date of Electronic Publication: 2021 Jul 15 (Print Publication: 2021).
Publication Type: Journal Article; Review
Journal Info: Publisher: e-Century Pub. Corp Country of Publication: United States NLM ID: 101493030 Publication Model: eCollection Cited Medium: Print ISSN: 1943-8141 (Print) Linking ISSN: 19438141 NLM ISO Abbreviation: Am J Transl Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1943-8141